Ko te tarukino "Glidiab MV": tohutohu mō te whakamahi, tūturu

Hoki te therapy tiaki o te momo tuarua o mate huka, i roto i nei taiāki te Kereru te hanga o ngā rāpoi ngota e hāngai ana i runga i nga tikanga e whakamahia ana gliclazide. Tenei taonga ko te pārōnaki sulfonylurea no ki te whakatupuranga tuarua.

āhuatanga General

Medicine "Glidiab MB 30" whakaaro te ki hei te ōrite Russian o "Diabeton MV" tarukino French. Wātea Chemical-ho'oraa Plant "Akrikhin" i roto i te rohe Moscow.

pā ana te medicament ki māngai hypoglycemic waha i roto i te puka papa he tuku whakarerekē. Tae ratou hanganga i te ma kia kirīmi whai mai mapere ranei. Papa rite ipurau flat he chamfer.

mōkihi Consumer Ko te mōkihi. Kia roto i te reira i 30 ranei 60 papa tākai i runga i mau api namunamu.

hanganga

Haunga te tarukino "Diabeton CF" ki te horopeta o 0,060 g gliclazide, y medicament "Glidiab CF" nui ōrite o te whakauru kaha i roto i te rua raro, i te mea 0,030 g

Na roto i te kai tableting hohekore ngā hydroxypropylmethylcellulose, aerosilovye rāpoi ngota, stearate konupora, microcrystalline cellulose.

He he ano hoki te tarukino "Glidiab" ki te tuku tikanga o te taonga kaha. Inenga ia papa 0.08 go o gliclazide.

Nahea

Āpitihia ki te medicament whakaahua ana "Glidiab MV" ā-ako te mahi o te gliclazide e puai whakaongaonga o secretion taiāki i β-pūtau, kei roto i te repe taiaki.

I raro i te mana o papa insulinosekretornaya nui haere mahi o nga rāpoi kūhuka me te kopa piringa riro atu tairongo ki taiāki taiki.

Uaua glycogen, he he paru intracellular whakaaturia te kakama nui. He he he whakaiti o te wā i te timatanga o te whakamahi o te kai ki te te tuku taiki. Ora taiāki secretion i te tihi wawe e rerekē i te tahi atu precursors gliclazide sulfonylurea, e e wahi i roto i te wāhanga tuarua. Whakaitia postprandial kūhuka.

Te whakapai ake microcirculation puta i te whakakotahi i te adhesion mōtepe me pūtau Whakapūnoa uruhanga iaia, ka whakaiti te whanaketanga o ngā tukanga mikrotromboznyh atherosclerotic, nga tauhohe whakaiti o te whakakāhoretanga tūturu o clots toto. Heke kaha ki te whakautu hanganga receptor i roto i te oko toto i roto i te rāpoi ngota Adrenaline.

Ka taea e te raau pōturi iho te pūāhua retinopathy huka atamira, te i runga i nonproliferative. kaihoko maimoatanga auroa rite ki nga tikanga o mate huka kino tākihi whakatu wahi kawenga mō te tātari, hanga ana e ia taea te reira ki tino whakaiti i te excretion o te pūmua i roto i te mimi.

E kore e te tarukino ake i te taimaha o te tinana, engari ki runga ki te anga ke, heke e tika ana ki te pānga i runga i te atamira wawe o te tuku taiāki. e kore e whakapataritari ia nui ake insulinemia.

He aha te tono

tūtohu kaiwhakaako te whakamahi o te tarukino ki te huka nui i roto i te toto o te tohu tuarua. kawea maimoatanga i roto i te iti pānga i runga i te kai, me te korikori tinana āhua.

Hei medicament "Glidiab CF" tohu e pā ana ki te ārai o te ino i roto i disorders huka āhuatanga nephropathy, retinopathy, infarction myocardial me te patu.

Me pēhea te ki te whakamahi i

tīpakohia te tikanga dosing te mo ia manawanui takitahi, homai whakakitenga o te mate, te kukū o te kūhuka i te puku kau, me te i muri i 120 meneti i muri i te kohi kai.

Hoki raau taero "Glidiab MV" ako i runga i te tono e whakarite tuatahi horopeta ia rā o 0.03 g, i te mea ōrite ki te kotahi papa. whakaaturia ana tēnei kukū te i roto i ngā tūroro pakeke i muri i te tau o 65. Rongoā e whakamahia ana waha tetahi papa i roto i te ata, ka parakuihi.

Ki te tika, nui haere te inenga e nga rua wiki. Ko te mōrahi e whakaaetia i roto i te ra kotahi ki te tango e pā ana ki 0,120 g, e ōrite ana ki te 4 papa.

Ko te medicament "Glidiab CF" whakamahia i roto i te wahi o te taua ingoa ki te rongoā tuku tikanga, mā te whakamahi i 1-4 papa ia ra.

Ko tōna ngā ki te tikanga biguanide mahi hypoglycemic, Arepa-glucosidase inhibitor o te rāpoi ngota taiāki.

I roto i te disorders tākihi mahi ngoikore āhua ranei huru, ka te auau o te creatinine whakawātea iti iho i te 0.080 rita ia meneti, me te kore whakaiti i te dosing.

A, no te kore e taea e koe te tango i

Papa "Glidiab MV" tohutohu ako ā-ki te whakamahi i te puka tuatahi o te mate huka mate mate huka i ketones teitei i roto i te mimi, paresis pekitīlia i hyperosmolar pōroa, mate huka , me te precoma mō tafa nui, me te tahu injuries, ngā tukanga ngaukino ka tika te taiāki huka maimoatanga.

Contraindications: disorders nui o ate ranei tākihi mahi, whēkau tutukitanga waewae, huri i te absorption o kai, te whanaketanga o te huru hypoglycemic.

E kore e taea e koe te whakamahi i roto i ngā tūroro ki te kirika, leukopenia, hapū, uma-kai, me te ātete nui o kai, te raau taero.

hiahiatia tūpato te ka whakahaere rongoā, tiaki motuhake me te kōwhiringa o toketaá ki tūroro e whai waipiro fakafalala me kōtītiti i roto i te repe thyroid.

Āhuatanga o te maimoatanga

Na roto i te tarukino "Glidiab MV" ako i runga i te ngā ki te hiahia ki te ngā i te reira ki te iti-pūngoi kai kai ngā i te ihirangi warowaihā iti. E titau te reira aroturuki auau o te kukū o te kūhuka i te bloodstream i te ata, i mua me i muri i te kai.

Ki te i koe tafa decompensation ranei o te huru mate huka, pea te tikanga o te whakataki o te taiāki.

He gipoglikemichekogo faaararaa puta tukanga i roto i te whakamahi o te Ethyl waipiro, he kore-steroidal māngai anti-inflammatory me te ngaro o te kaha. Inu waipiro e taea meinga disulfiramopodobnyh syndrome, me ka maru ai te upoko me te puku, whakapairuaki, me te ruaki.

He mea tika ki te whakatika i te inenga o te rongoā i roto i te ahotea tinana ranei aronganui me te kai materoto.
Rawa tairongo ki te pānga o te tikanga ko te ruhiruhia, tūroro ki te kai tōtika tahatahi ranei rawakore, tūroro debilitated nei mamae i hē o te pūnaha adrenal-rapae o.

I roto i te wāhanga tuatahi o te tono o te raau taero i roto i te kōwhiringa o te inenga, ki te mea i reira te mea he predisposition ki raruraru hypoglycemic, e kore te mea e tika ana ki te mahi mahi e hiahia whakarongo me ngā hohenga whakamātau tinana tere nui haere.

tauhohe kino

Na roto o "Glidiab MV" ako ngā pārongo i runga i maumaui i roto i te okana endocrine i roto i te kore i roto i te aratau papa, te whakamahi, me te rawakore kai tōtika. Ko te tikanga, whakaiti o te kūhuka i te bloodstream ai te takanga o te mamae upoko, rohirohi, hiakai, mii, manukanuka he inamata ngoikore, fakaaoao, kukū rawakore, āhua fakalotofo'í. Hoki i reira he huringa o te perception ataata, faaati, pa me te mate takiri, whanoke, gipersomniyai, manawa pāpaku, heke auau ngakau.

whekau kūnatu hua malfunctions i te puka o te malabsorption, whakapairuaki, korere, kore o te hiahia anorexic, whakararuraru o mahi pūtau ate, jaundice cholestatic, ake i te tōtika o whākōkī transaminase.

tukanga houhou i roto i te pūnaha hematopoietic e pā ana ki te hekenga i roto i pūtoto, me te leukocyte tau mōtepe pūtau.

Ka taea e te tarukino meinga tauhohe mate pāwera i roto i te puka o te patito, urticaria, ponana makulo-papular.

whakataki nui

Āpitihia ki te tikanga "Glidiab MV" ako i runga i te fakatokanga ki he tuwhena rawa, faaite nei e te hekenga i roto i te wē kūhuka kukū. Ki te kia whakawhanake i tētahi rongoā kaha te taikaha pōroa hypoglycemic.

Hei whakakore i homai he tangata e iti ki te kai waiwaro pai whenumi, hei tauira, he wahi o te huka. A, no te te tangata he kohatu, whakaurua ia ki te rua 40 ōrau tēhuka kūhuka ranei otinga, me te wero ki te uaua o te glucagon i roto i te nui o te 1 mg. Ki te ko te manawanui e ara, ka te takoha ia ki te kai waiwaro pai whenumi ki te karo whakaeke hypoglycemic tukurua.

Ko te huinga ki te rongoā

Ka taea te whakarei i te mahi hypoglycemic o te medicament "Glidiab CF 30 mg" i te whakauru retarder whakarara angiotensin tahuri whākōkī me Monoamine momo oxidase receptor adrenozavisimyh ngā pūārai peta me H2 gistaminozavisimyh hāngai cimetidine, a flukonazolovyh taero antifungal mikonazolovyh, kore-steroidal anti-inflammatory āpiha phenylbutazone, indomethacin, diclofenac.

Ko te pānga o nga papa te rongo nui haere te whakamahi i clofibrate me bezafibrate, ethionamide taero antitubercular i te rōpū o salicylates, autaki pūhui anticoagulant o te hanganga coumarin, steroids anabolic, cyclophosphamide, chloramphenicol, sulfonamides ki te pānga auroa.

tōtika te raau Whakahekea huka i roto i te wē toto mā te whakamahi i blockers o papī tubular, Ethyl waipiro, acarbose, he biguanide, taiāki.

meinga papa pānga hypoglycemic iti barbiturates, ngā rongoā e hāngai ana epinephrine, clonidine, terbutaline, ritodrine, salbutamol, ara phenytoin, inhibitors o carbonic momo anhydrase paru acetazolamide, Diuretics thiazide, hormones o te repe thyroid, taero lithium-kei roto, rongoā estrogen.

Ka taea e Ethyl waipiro muingota whakaawe i te putanga o te tukanga gliclazide disulfiramopodobnyh.

Papa wāhanga Hohe meinga depolarization materoto, me te ventricular uaua auheke myocardial ka ngā ki glycosides cardiac.

tikanga adrenoblokatornye Beta klonidinovye, reserpine, taero guanetidinovye huna kanohi te suka haumanu.

Tirohanga o tūroro

e kore e piri anake te reira ki te medicament "Glidiab MV" ako ā-ringa. kōrero arotake e pā ana ki te mea tūroro whakaaro e pā ana ki te whai huatanga o te tarukino. āwhina ana tēnei taputapu maha tūroro ki te whakaiti i te kukū o te te kūhuka ki ngā taumata noa, a i roto i ngā ki kai taui te whakapakoko o te ora o te manawanui.

People mea e te āhuatanga pai o te papa, ko tona whakamahi watea i te ata. Ka rite ki a koutou e kore e taea mahara te hiahia mo te maimoatanga i roto i te ra.

I rongoa "Glidiab MV" taea te rongo arotake me te pūāhua kino e pā ana ki te memeha noa o tenei taputapu. Ko te tikanga tupu tenei ka te dosing he ka te nui iti o te rongoā tikanga.